FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roser Torra

Research Profile

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Josep M Campistol; Mario Espinosa; Josep M Grinyó; Manuel Praga; Manuel Arias; Gema Ariceta; Marisa Blasco; Roser Torra; Ramon Vilalta; Santiago Rodríguez de Córdoba
An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
Johanna Temme; Roser Torra; Manfred Weber; Jean-Pierre Grunfeld; Laurence Heidet; Katharina Lange; Christoph Licht; Gerhard-Anton Müller; Frederick Peters; Yves Pirson; Oliver Gross
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations.
Oliver Gross; Jean-Pierre Grunfeld; Laurence Heidet; Britta Höcker; Bernd Hoppe; Peter Hoyer; bertrand knebelmann; Martin Konrad; Katharina Lange; Said Lebbah; Christoph Licht; Gerhard A Müller; Dirk E Müller-Wiefel; Patrick Niaudet; Lars Pape; Yves Pirson; Wolfgang Rascher; Burkhard Tönshoff; Roser Torra; Hans J Anders; Bodo Beck; Pierre Cochat; Jörg Dötsch; Jochen H H Ehrich; Tim Friede; Simone Wygoda; Manfred Weber
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roser Torra (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Josep M Campistol; Mario Espinosa; Josep M Grinyó; Manuel Praga; Manuel Arias; Gema Ariceta; Marisa Blasco; Roser Torra; Ramon Vilalta; Santiago Rodríguez de Córdoba
An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2013;33(1):27-45.
2012: Johanna Temme; Roser Torra; Manfred Weber; Jean-Pierre Grunfeld; Laurence Heidet; Katharina Lange; Christoph Licht; Gerhard-Anton Müller; Frederick Peters; Yves Pirson; Oliver Gross
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations.
Kidney international 2012;81(8):779-83.
2012: Oliver Gross; Jean-Pierre Grunfeld; Laurence Heidet; Britta Höcker; Bernd Hoppe; Peter Hoyer; bertrand knebelmann; Martin Konrad; Katharina Lange; Said Lebbah; Christoph Licht; Gerhard A Müller; Dirk E Müller-Wiefel; Patrick Niaudet; Lars Pape; Yves Pirson; Wolfgang Rascher; Burkhard Tönshoff; Roser Torra; Hans J Anders; Bodo Beck; Pierre Cochat; Jörg Dötsch; Jochen H H Ehrich; Tim Friede; Simone Wygoda; Manfred Weber
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.
Kidney international 2012;81(5):494-501.
2012: Cristina Cabrera-López; Violeta Catalá; Teresa Martí; Silvia Mateu; José Ballarín; Ferran Torres; Roser Torra
Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial.
Orphanet journal of rare diseases 2012;7():87.
2011: S Santín; M Torrent; Elisabet Ars; José Ballarín; G Fraga; T Martí; Nuria Pardo; P Ruíz; Roser Torra
WT1 mutations may be a cause of severe renal failure due to nephroblastomatosis in Wilms' tumor patients.
Clinical nephrology 2011;76(3):244-8.
2011: Sheila Santín; Bárbara Tazón Vega; Irene Silva; María Ángeles Cobo; Isabel Giménez; Patricia Ruíz; Rafael García-Maset; José Ballarín; Roser Torra; Elisabet Ars
Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(2):344-54.
2010: Mihailo Vujic; Christina M Heyer; Elisabet Ars; Katharina Hopp; Arseni Markoff; Charlotte Orndal; Bengt Rudenhed; Samih H Nasr; Vicente E Torres; Roser Torra; Nadja Bogdanova; Peter C Harris
Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.
Journal of the American Society of Nephrology : JASN 2010;21(7):1097-102.
2008: Fernando C Fervenza; Roser Torra; David G Warnock
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease.
Biologics : targets & therapy 2008;2(4):823-43.
2008: Roser Torra; Joaquim Sarquella; Jordi Calabia; Jordi Martí; Elisabet Ars; Patricia Fernández-Llama; Jose Ballarin
Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(3):790-3.
2008: Fernando C Fervenza; Roser Torra; Donna J Lager
Fabry disease: an underrecognized cause of proteinuria.
Kidney international 2008;73(10):1193-9.
2008: Roser Torra
[New therapeutic prospects in autosomal dominant polycystic kidney disease].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2008;28(3):257-62.
2007: Cristina Esteva-Font; Elisabet Ars; Elena Guillen-Gomez; Josep Maria Campistol; Laia Sanz; Wladimiro Jiménez; Mark Alan Knepper; Ferran Torres; Roser Torra; José Ballarín; Patricia Fernández-Llama
Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(10):2810-6.
2007: Bárbara Tazón Vega; Elisabet Ars; Moisès Burset; Sheila Santín; Patricia Ruíz; Patricia Fernández-Llama; José Ballarín; Roser Torra
Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;50(2):257.e1-14.
2007: Bárbara Tazón Vega; Mireia Vilardell; Laureano Pérez-Oller; Elisabet Ars; Patricia Ruiz; Olivier Devuyst; Xose Lens; Patricia Fernández-Llama; José Ballarín; Roser Torra
Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1567-77.
2005: Elisabet Ars; Bárbara Tazón Vega; Patricia Ruiz; Carme Nogués; Núria Arnedo; Osvaldo Rajmil; Roser Torra
Male-to-male transmission of X-linked Alport syndrome in a boy with a 47,XXY karyotype.
European journal of human genetics : EJHG 2005;13(9):1040-6.
2005: Roser Torra; José Ballarín
[Renal hereditary diseases. The role of primary care].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2005;25 Suppl 4():89-91.
2005: Roser Torra; Baacuterbara Tazón; Elisabet Ars; José Ballarín
[Collagen IV (alpha3-alpha4) nephropathy].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2005;25 Suppl 2():29-32.
2005: Mark B Consugar; Sarah A Anderson; Sandro Rossetti; V Shane Pankratz; Christopher J Ward; Roser Torra; Eliecer Coto; Mounif El-Youssef; Sibel Kantarci; Boris Utsch; Friedhelm Hildebrandt; William E Sweeney; Ellis D Avner; Vicente E Torres; Julie M Cunningham; Peter C Harris
Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):77-87.
2004: Roser Torra; Bárbara Tazón Vega; Elisabet Ars; José Ballarín
Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(10):2429-32.
2003: Bárbara Tazón Vega; Cèlia Badenas; Elisabet Ars; Xose Lens; Montserrat Milà; Alejandro Darnell; Roser Torra
Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(5):952-9.
2003: Christopher J Ward; David Yuan; Tatyana V Masyuk; Xiaofang Wang; Rachaneekorn Punyashthiti; Shelly Whelan; Robert L Bacallao; Roser Torra; Nicholas F LaRusso; Vicente E Torres; Peter C Harris
Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia.
Human molecular genetics 2003;12(20):2703-10.
2003: Sandro Rossetti; Roser Torra; Eliecer Coto; Mark B Consugar; Vickie Kubly; Serafín Málaga; Mercedes Navarro; Mounif El-Youssef; Vicente E Torres; Peter C Harris
A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees.
Kidney international 2003;64(2):391-403.
2003: riccardo magistroni; Ning He; Kairong Wang; Robin Andrew; Ann Johnson; Patricia Gabow; Elizabeth Dicks; Patrick Parfrey; Roser Torra; Jose L San-Millan; Eliecer Coto; Marjan Van Dijk; Martijn H Breuning; Dorien Peters; Nadja Bogdanova; Guido Ligabue; Alberto Albertazzi; Nick Hateboer; Kyproula Demetriou; Alkis Pierides; C Constantinou Deltas; Peter St George-Hyslop; David Ravine; York Pei
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.
Journal of the American Society of Nephrology : JASN 2003;14(5):1164-74.
2003: Roser Torra; José Ballarín
[The Fabry's disease].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2003;23 Suppl 1():84-9.
2003: Manuel Praga; Roser Torra; Baacuterbara Tazón
[Familial benign hematuria].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2003;23 Suppl 1():40-5.
2003: Baacuterbara Tazón; Elisabet Ars; Roser Torra
[The Alport syndrome].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2003;23 Suppl 1():29-39.
2003: Elisabet Ars; Roser Torra; A Oliver
[Molecular diagnosis of hereditary renal diseases].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2003;23 Suppl 1():2-10.
2002: Cèlia Badenas; Manuel Praga; Baacuterbara Tazón; Laurence Heidet; Christelle Arrondel; Anna Armengol; Amado Andrés; Enrique Morales; Juan Antonio Camacho; Xose Lens; Sonia Dávila; Montserrat Milà; Corinne Antignac; Alejandro Darnell; Roser Torra
Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria.
Journal of the American Society of Nephrology : JASN 2002;13(5):1248-54.
2000: Roser Torra; Cèlia Badenas; Laureano Pérez-Oller; J Luis; S Millán; Carlos Nicolau; F Oppenheimer; Montserrat Milà; Alejandro Darnell
Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;36(4):728-34.
2000: Carlos Nicolau; Roser Torra; Cèlia Badenas; L Pérez; J A Oliver; Alejandro Darnell; Concepció Brú
Sonographic pattern of recessive polycystic kidney disease in young adults. Differences from the dominant form.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(9):1373-8.
2000: Cèlia Badenas; Roser Torra; Laureano Pérez-Oller; J Mallolas; R Talbot-Wright; V Torregrosa; Alejandro Darnell
Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.
European journal of human genetics : EJHG 2000;8(7):487-92.
2000: Carlos Nicolau; Roser Torra; L Bianchi; Ramón Vilana; Rosa Gilabert; Alejandro Darnell; Concepció Brú
Abdominal sonographic study of autosomal dominant polycystic kidney disease.
Journal of clinical ultrasound : JCU 2000;28(6):277-82.
2000: Nick Hateboer; Barbara Veldhuisen; D Peters; Martijn H Breuning; José L San Millán; Nadja Bogdanova; Eliecer Coto; Meindert A van Dijk; Ali R Afzal; Steve Jeffery; Anand K Saggar-Malik; Roser Torra; D Dimitrakov; I Martinez; S S de Castro; M Krawczak; David Ravine
Location of mutations within the PKD2 gene influences clinical outcome.
Kidney international 2000;57(4):1444-51.
2000: Laureano Pérez-Oller; Roser Torra; Cèlia Badenas; José L San Millán; Alejandro Darnell
[Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2000;20(2):130-8.
2000: Roser Torra; Cèlia Badenas; Laureano Pérez-Oller; José L San Millán; Dolores Tellería; Xavier Estivill; Alejandro Darnell
[Mutational analysis of the PKD1 and PKD2 (type 1 and 2 dominant autosomal polycystic kidney) genes].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2000;20(1):39-46.
1999: Carlos Nicolau; Roser Torra; Cèlia Badenas; Ramón Vilana; L Bianchi; Rosa Gilabert; Alejandro Darnell; Concepció Brú
Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis.
Radiology 1999;213(1):273-6.
1999: Laureano Pérez-Oller; Roser Torra; Cèlia Badenas; Montserrat Milà; Alejandro Darnell
Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(2):273-8.
1999: Roser Torra; Cèlia Badenas; José L San Millán; Laureano Pérez-Oller; Xavier Estivill; Alejandro Darnell
A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2.
American journal of human genetics 1999;65(2):345-52.
1999: Roser Torra; M Viribay; Dolores Tellería; Cèlia Badenas; M Watson; P Harris; Alejandro Darnell; José L San Millán
Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease.
Kidney international 1999;56(1):28-33.
1999: Albert C M Ong; Christopher J Ward; R J Butler; SC Biddolph; Colene Bowker; Roser Torra; Y Pei; Peter C Harris
Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue.
The American journal of pathology 1999;154(6):1721-9.
1999: Cèlia Badenas; Roser Torra; José L San Millán; L Lucero; Montserrat Milà; X Estivill; Alejandro Darnell
Mutational analysis within the 3' region of the PKD1 gene.
Kidney international 1999;55(4):1225-33.
1999: Roser Torra; Cèlia Badenas; F Cofán; L Callis; Laureano Pérez-Oller; Alejandro Darnell
Autosomal recessive Alport syndrome: linkage analysis and clinical features in two families.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(3):627-30.
1999: Nick Hateboer; M A v Dijk; Nadja Bogdanova; Eliecer Coto; Anand K Saggar-Malik; J L San Millan; Roser Torra; Martijn H Breuning; David Ravine
Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group.
Lancet 1999;353(9147):103-7.
1999: Roser Torra
Autosomal dominant polycystic kidney disease, type 2 (PKD2 disease).
Advances in nephrology from the Necker Hospital 1999;29():277-87.
1998: Roser Torra; Cèlia Badenas; Alejandro Darnell; J A Camacho; R Aspinwall; Peter C Harris; Xavier Estivill
Facilitated diagnosis of the contiguous gene syndrome: tuberous sclerosis and polycystic kidneys by means of haplotype studies.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(6):1038-43.
1998: Laureà Pérez; Roser Torra; Cèlia Badenas; Jordi Ara; Elisabeth Coll; J Moisés; Alejandro Darnell
Autosomal recessive polycystic kidney disease presenting in adulthood. Molecular diagnosis of the family.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(5):1273-6.
1998: Roser Torra; Cèlia Badenas; Alejandro Darnell; Carlos Nicolau; V Volpini; L Revert; Xavier Estivill
[Clinical, genetic and molecular studies on autosomal dominant polycystic kidney disease].
Medicina clínica 1998;110(13):481-7.
1998: Roser Torra; Cèlia Badenas; B Peral; Alejandro Darnell; Eduard Serra; V Gamble; A E Turco; Peter C Harris; Xavier Estivill
Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families.
Human mutation 1998;Suppl 1():S117-20.
1997: Roser Torra; Cèlia Badenas; Alejandro Darnell; Concepció Brú; Angels Escorsell; Xavier Estivill
Autosomal dominant polycystic kidney disease with anticipation and Caroli's disease associated with a PKD1 mutation. Rapid communication.
Kidney international 1997;52(1):33-8.
1997: Elisabeth Coll; Roser Torra; Jordi Pascual; Albert Botey; Jordi Ara; Laureà Pérez; F Ballesta; Alejandro Darnell
Sporadic orofaciodigital syndrome type I presenting as end-stage renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(5):1040-2.
1997: Cèlia Badenas; Roser Torra; Alejandro Darnell; X Estivill
Mutations and intragenic polymorphisms in the diagnosis of autosomal dominant polycystic kidney disease type 1.
Contributions to nephrology 1997;122():45-8.
1997: Roser Torra; Cèlia Badenas; L Pérez; X Estivill; Alejandro Darnell
Hypertension in polycystic kidney disease type 1 and 2 and its effect on the age of onset of end-stage renal disease.
Contributions to nephrology 1997;122():28-30.
1997: Roser Torra; Carlos Nicolau; Cèlia Badenas; S Navarro; L Pérez; X Estivill; Alejandro Darnell
Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease.
Clinical nephrology 1997;47(1):19-22.
1996: Roser Torra; Carlos Nicolau; Cèlia Badenas; Concepció Brú; L Pérez; Xavier Estivill; Alejandro Darnell
Abdominal aortic aneurysms and autosomal dominant polycystic kidney disease.
Journal of the American Society of Nephrology : JASN 1996;7(11):2483-6.
1996: Roser Torra; Cèlia Badenas; Alejandro Darnell; Carlos Nicolau; V Volpini; L Revert; Xavier Estivill
Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.
Journal of the American Society of Nephrology : JASN 1996;7(10):2142-51.
1996: Roser Torra; L Alós; J Ramos; Xavier Estivill
Renal-hepatic-pancreatic dysplasia: an autosomal recessive malformation.
Journal of medical genetics 1996;33(5):409-12.
1995: Roser Torra; Alejandro Darnell; Xavier Estivill; A Botey; L Revert
Interfamilial and intrafamilial variability of clinical expression in ADPKD.
Contributions to nephrology 1995;115():97-101.
1995: Roser Torra; Alejandro Darnell; M Cleries; A Botey; L Revert; E Vela
Polycystic kidney disease patients on renal replacement therapy: data from the Catalan Renal Registry.
Contributions to nephrology 1995;115():177-81.
1995: Roser Torra; Alejandro Darnell; Albert Botey; L Revert
Chronic neutropenia and cryoglobulinemic nephropathy: effectiveness of treatment.
Nephron 1995;69(1):87-8.
1994: R Cervera; F Cardellach; Roser Torra; M Navarro; B Coll-Vinent; A Botey
Severe acute multi-organ complications in the 'primary' antiphospholipid syndrome: it is appropriate to use the 'catastrophic' adjective.
Clinical and experimental rheumatology 1994;12(3):345; author reply 346.
1994: Roser Torra; Rosa Gilabert; L Fernández-Cruz; María José Ricart; Enric Esmatjes; S Gonzalez; Federico Oppenheimer
Acute abdominal pain after vesical catheterization in a kidney and pancreas graft recipient.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7(6):448-9.
1993: Roser Torra; Esteban Poch; A Torras; J A Bombí; L Revert
Pulmonary hemorrhage as a clinical manifestation of hemolytic-uremic syndrome associated with mitomycin C therapy.
Chemotherapy 1993;39(6):453-6.
1992: Patricio Luburich; Carlos Nicolau; M C Ayuso; Roser Torra; J A Clavero
Pelvic Castleman disease: CT and MR appearance.
Journal of computer assisted tomography 1992;16(4):657-9.